Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human interferon alpha-1b by different administration routes for infant bronchiolitis
ChiCTR-IPR-14005413Phase 4Recruiting
- Sponsor
- West China Second University Hospital
- Start
- Oct 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of recombinant human interferon alpha-1b in bronchiolitis (4 arms), sponsored by West China Second University Hospital. Primary endpoints: Degree of cyanosis, Breathing level and 1 more. Started Oct 2014; status: recruiting.
02
Drugs
recombinant human interferon alpha-1b
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on ChiCTR-IPR-14005413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005413.